[Acidrine in the treatment of diseases caused by hydrochloropeptic hypersecretion].
D000328:Adult; D000368:Aged; D000535:Aluminum / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D005756:Gastritis / Q000188:drug therapy*; D005759:Gastroenteritis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D011134:Polysaccharides / Q000627:therapeutic use*
D000863:Antacids; D001952:Bridged-Ring Compounds; D004338:Drug Combinations; D009942:Organometallic Compounds; D011134:Polysaccharides; C011625:aluminium glycinate, myrtecaine drug combination; D000535:Aluminum
L'acidrine nel trattamento di alcune malattie da ipersecrezione cloridropeptica.